Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Pain Therapeutics begins phase II opioid pain medication trial

Oct. 20, 2000

Preparation, activity and use of new acetylcholinesterase inhibitors reported by Eisai

Oct. 19, 2000

Antidepressant-like activity observed in validated animal model for NK1 receptor antagonist

Oct. 19, 2000

Priority review status issued for Xyrem

Oct. 18, 2000

Second IND filed in Canada for Theratechnologies' GH-releasing analogue

Oct. 18, 2000

Kyorin patents new AMPA receptor antagonists and their use

Oct. 17, 2000

FDA approves Novantrone for worsening forms of multiple sclerosis

Oct. 17, 2000

Successful treatment of breakthrough pain with intranasal morphine

Oct. 17, 2000

Tempol exerts short- and long-term protective effects in stroke model

Oct. 17, 2000

NPS-1506: a summary of data up to early clinical trials in stroke patients

Oct. 17, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
K2 nabs two Antengene bispecific TCEs in $2B license, option deal
BioWorld
MPM Bioimpact-spawned K2 Therapeutics Inc. inked a license deal plus option agreement, worth $980.5 million apiece, to gain ex-China rights to two of Antengene...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...